Amino-terminal phosphorylation of activation-induced cytidine deaminase suppresses c-myc/IgH translocation

Molecular and Cellular Biology

Volumn 31, Issue 3, 2011, Pages 442-449

  Gazumyan, Anna ^a,b   Timachova, Ksenia ^a   Yuen, Grace ^a   Siden, Edward ^c   Di Virgilio, Michela ^a   Woo, Eileen M ^a   Chait, Brian T ^a   San Martin, Bernardo Reina ^d   Nussenzweig, Michel C ^a,b   McBride, Kevin M ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c Felician College   (United States)

^d INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CYTIDINE DEAMINASE; PROTEIN PP2A; SERINE; THREONINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CATALYSIS; DOWN REGULATION; ENZYME ACTIVATION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; IN VIVO STUDY; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SEQUENCE ALIGNMENT;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; CYTIDINE DEAMINASE; ENZYME INHIBITORS; FIBROBLASTS; IMMUNOGLOBULIN CLASS SWITCHING; IMMUNOGLOBULIN HEAVY CHAINS; MICE; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; PHOSPHORYLATION; PHOSPHOSERINE; PROTEIN PHOSPHATASE 2; PROTO-ONCOGENE PROTEINS C-MYC; RECOMBINATION, GENETIC; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN; TRANSLOCATION, GENETIC;

EID: 78751554059     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00349-10     Document Type: Article

References (60)

1. Aoufouchi, S., et al. 2008. Proteasomal degradation restricts the nuclear lifespan of AID. J. Exp. Med. 205:1357-1368.
2. Arroyo, J. D., and W. C. Hahn. 2005. Involvement of PP2A in viral and cellular transformation. Oncogene 24:7746-7755.
3. Basu, U., et al. 2005. The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation. Nature 438:508-511.
4. Bransteitter, R., P. Pham, M. D. Scharff, and M. F. Goodman. 2003. Activation-induced cytidine deaminase deaminates deoxycytidine on singlestranded DNA but requires the action of RNase. Proc. Natl. Acad. Sci. U. S. A. 100:4102-4107.
5. Brar, S. S., M. Watson, and M. Diaz. 2004. Activation-induced cytosine deaminase (AID) is actively exported out of the nucleus but retained by the induction of DNA breaks. J. Biol. Chem. 279:26395-26401.
6. Chatterji, M., S. Unniraman, K. M. McBride, and D. G. Schatz. 2007. Role of activation-induced deaminase protein kinase A phosphorylation sites in Ig gene conversion and somatic hypermutation. J. Immunol. 179:5274-5280.
7. Chaudhuri, J., C. Khuong, and F. W. Alt. 2004. Replication protein A interacts with AID to promote deamination of somatic hypermutation targets. Nature 430:992-998.
8. Chaudhuri, J., et al. 2003. Transcription-targeted DNA deamination by the AID antibody diversification enzyme. Nature 422:726-730. (Pubitemid 36514112)
9. Cheng, H. L., et al. 2009. Integrity of the AID serine-38 phosphorylation site is critical for class switch recombination and somatic hypermutation in mice. Proc. Natl. Acad. Sci. U. S. A. 106:2717-2722.
10. Cohen, P., S. Klumpp, and D. L. Schelling. 1989. An improved procedure for identifying and quantitating protein phosphatases in mammalian tissues. FEBS Lett. 250:596-600.
11. de Yebenes, V. G., et al. 2008. miR-181b negatively regulates activation-induced cytidine deaminase in B cells. J. Exp. Med. 205:2199-2206.
12. Dickerson, S. K., E. Market, E. Besmer, and F. N. Papavasiliou. 2003. AID mediates hypermutation by deaminating single stranded DNA. J. Exp. Med. 197:1291-1296.
13. Di Noia, J., and M. Neuberger. 2007. Molecular mechanisms of antibody somatic hypermutation. Annu. Rev. Biochem. 76:1-22.
14. Dorsett, Y., et al. 2008. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity 28:630-638.
15. Dorsett, Y., et al. 2007. A role for AID in chromosome translocations between c-myc and the IgH variable region. J. Exp. Med. 204:2225-2232.
16. Eichhorn, P. J., M. P. Creyghton, and R. Bernards. 2009. Protein phosphatase 2A regulatory subunits and cancer. Biochim. Biophys. Acta 1795: 1-15.
17. Fugmann, S. D., A. I. Lee, P. E. Shockett, I. J. Villey, and D. G. Schatz. 2000. The RAG proteins and V(D)J recombination: complexes, ends, and transposition. Annu. Rev. Immunol. 18:495-527.
18. Ito, S., et al. 2004. Activation-induced cytidine deaminase shuttles between nucleus and cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1. Proc. Natl. Acad. Sci. U. S. A. 101:1975-1980.
19. Jankovic, M., A. Nussenzweig, and M. C. Nussenzweig. 2007. Antigen receptor diversification and chromosome translocations. Nat. Immunol. 8:801-808.
20. Janssens, V., and J. Goris. 2001. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem. J. 353:417-439.
21. Janssens, V., J. Goris, and C. Van Hoof. 2005. PP2A: the expected tumor suppressor. Curr. Opin. Genet. Dev. 15:34-41.
22. Jaramillo-Babb, V. L., et al. 1996. Positive regulation of cdc2 gene activity by protein phosphatase type 2A. J. Biol. Chem. 271:5988-5992.
23. Jung, D., C. Giallourakis, R. Mostoslavsky, and F. W. Alt. 2006. Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus. Annu. Rev. Immunol. 24:541-570.
24. Klemm, L., et al. 2009. The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia. Cancer Cell 16:232-245.
25. Kovalchuk, A. L., J. R. Muller, and S. Janz. 1997. Deletional remodeling of c-myc-deregulating chromosomal translocations. Oncogene 15:2369-2377.
26. Li, Y. M., C. Mackintosh, and J. E. Casida. 1993. Protein phosphatase 2A and its [3H]cantharidin/[3H]endothall thioanhydride binding site. Inhibitor specificity of cantharidin and ATP analogues. Biochem. Pharmacol. 46:1435-1443.
27. Liu, M., et al. 2008. Two levels of protection for the B cell genome during somatic hypermutation. Nature 451:841-845.
28. Liu, M., and D. G. Schatz. 2009. Balancing AID and DNA repair during somatic hypermutation. Trends Immunol. 30:173-181.
29. McBride, K. M., V. Barreto, A. R. Ramiro, P. Stavropoulos, and M. C. Nussenzweig. 2004. Somatic hypermutation is limited by CRM1-dependent nuclear export of activation-induced deaminase. J. Exp. Med. 199:1235-1244.
30. McBride, K. M., et al. 2006. Regulation of hypermutation by activation-induced cytidine deaminase phosphorylation. Proc. Natl. Acad. Sci. U. S. A. 103:8798-8803.
31. McBride, K. M., et al. 2008. Regulation of class switch recombination and somatic mutation by AID phosphorylation. J. Exp. Med. 205:2585-2594.
32. Mumby, M. 2007. PP2A: unveiling a reluctant tumor suppressor. Cell 130: 21-24.
33. Muramatsu, M., et al. 2000. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102:553-563.
34. Muramatsu, M., et al. 1999. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol. Chem. 274:18470-18476.
35. Nussenzweig, A., and M. C. Nussenzweig. Origin of chromosomal translocations in lymphoid cancer. Cell 141:27-38.
36. Pasqualucci, L., Y. Kitaura, H. Gu, and R. Dalla-Favera. 2006. PKA-mediated phosphorylation regulates the function of activation-induced deaminase (AID) in B cells. Proc. Natl. Acad. Sci. U. S. A. 103:395-400.
37. Pasqualucci, L., et al. 1998. BCL-6 mutations in normal germinal center B cells: evidence of somatic hypermutation acting outside Ig loci. Proc. Natl. Acad. Sci. U. S. A. 95:11816-11821.
38. Patenaude, A. M., et al. 2009. Active nuclear import and cytoplasmic retention of activation-induced deaminase. Nat. Struct. Mol. Biol. 16:517-527.
39. Pavri, R., et al. 2010. Activation-induced cytidine deaminase targets DNA at sites of RNA polymerase II stalling by interaction with Spt5. Cell 143:122-133.
40. Peled, J. U., et al. 2008. The biochemistry of somatic hypermutation. Annu. Rev. Immunol. 26:481-511.
41. Perrotti, D., and P. Neviani. 2008. Protein phosphatase 2A (PP2A), a drugable tumor suppressor in Ph1(+) leukemias. Cancer Metastasis Rev. 27:159-168.
42. Petersen-Mahrt, S. K., R. S. Harris, and M. S. Neuberger. 2002. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 418:99-103.
43. Pham, P., et al. 2008. Impact of phosphorylation and phosphorylation-null mutants on the activity and deamination specificity of activation-induced cytidine deaminase. J. Biol. Chem. 283:17428-17439.
44. Rajewsky, K. 1996. Clonal selection and learning in the antibody system. Nature 381:751-758. (Pubitemid 26243107)
45. Ramiro, A., et al. 2007. The role of activation-induced deaminase in antibody diversification and chromosome translocations. Adv. Immunol. 94:75-107.
46. Ramiro, A. R., et al. 2006. Role of genomic instability and p53 in AID-induced c-myc-Igh translocations. Nature 440:105-109.
47. Ramiro, A. R., et al. 2004. AID is required for c-myc/IgH chromosome translocations in vivo. Cell 118:431-438.
48. Ramiro, A. R., P. Stavropoulos, M. Jankovic, and M. C. Nussenzweig. 2003. Transcription enhances AID-mediated cytidine deamination by exposing single-stranded DNA on the nontemplate strand. Nat. Immunol. 4:452-456.
49. Revy, P., et al. 2000. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102:565-575.
50. Robbiani, D. F., et al. 2008. AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations. Cell 135:1028-1038.
51. Robbiani, D. F., et al. 2009. AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations. Mol. Cell 36:631-641.
52. Shen, H. M., A. Peters, B. Baron, X. Zhu, and U. Storb. 1998. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 280:1750-1752.
53. Stavnezer, J., J. E. Guikema, and C. E. Schrader. 2008. Mechanism and regulation of class switch recombination. Annu. Rev. Immunol. 26:261-292.
54. Teng, G., et al. 2008. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 28:621-629.
55. Teng, G., and F. N. Papavasiliou. 2007. Immunoglobulin somatic hypermutation. Annu. Rev. Genet. 41:107-120.
56. Virshup, D. M., and S. Shenolikar. 2009. From promiscuity to precision: protein phosphatases get a makeover. Mol. Cell 33:537-545.
57. Vuong, B. Q., et al. 2009. Specific recruitment of protein kinase A to the immunoglobulin locus regulates class-switch recombination. Nat. Immunol. 10:420-426.
58. Wang, M., Z. Yang, C. Rada, and M. S. Neuberger. 2009. AID upmutants isolated using a high-throughput screen highlight the immunity/cancer balance limiting DNA deaminase activity. Nat. Struct. Mol. Biol. 16:769-776.
59. Westermarck, J., and W. C. Hahn. 2008. Multiple pathways regulated by the tumor suppressor PP2A in transformation. Trends Mol. Med. 14:152-160.
60. Yoshikawa, K., et al. 2002. AID enzyme-induced hypermutation in an actively transcribed gene in fibroblasts. Science 296:2033-2036. (Pubitemid 34627527)